CLINICAL PHARMACOLOGY OF MIAMI, LLC

CPMI has a 30-year history of providing its clients with unique capabilities, executing on complex trials in normal healthy volunteers and highly specialized populations. Well known for its ability to enroll in studies targeting renal insufficiency, hepatic impairment, T2DM, dermatology, elderly healthy subjects, post-menopausal women, sexual dysfunction (male and female), smoking cessation and obesity, CPMI continues to expand into new indications. The 120-bed Phase I unit is a preferred site for many large pharmaceutical sponsors, biotechnology and specialty pharmaceutical companies. Additionally, several clinical research organization clients trust CPMIs established team to deliver when their own Phase I units are at...

Phase i research,bioequivalence,sad/mad,first-in-human,tqt,cardiac safety,and first-to-file

Clinical pharmacology of miami, llc operates in the Pharmaceutical manufacturing industry.

Clinical pharmacology of miami, llc's revenue is 11m - 100m

Clinical pharmacology of miami, llc has 11 - 50 employees.